Guangzhou Baiyunshan Pharmaceutical Holdings (600332.SH): Ceftazidime for Injection Passes Generic Drug Consistency Evaluation

Stock News

Sep 03

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SH) announced that its controlling subsidiary, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. ("Tianxin Pharmaceutical"), has received the "Drug Supplemental Application Approval Notice" issued by the National Medical Products Administration. The company's Ceftazidime for Injection (0.5g, 1.0g) has successfully passed the generic drug quality and efficacy consistency evaluation.

Ceftazidime for Injection is a third-generation cephalosporin antibiotic indicated for the treatment of single or multiple infections caused by susceptible microorganisms, including: systemic severe infections; lower respiratory tract infections (including pneumonia); ear, nose, and throat infections; urinary tract infections; skin and soft tissue infections; bone and joint infections; gynecological infections; gastrointestinal, biliary, and abdominal infections; hemodialysis/peritoneal dialysis and continuous ambulatory peritoneal dialysis (CAPD)-related infections; central nervous system infections (including meningitis); and prevention of perioperative urinary tract infections.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1132935565"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1132935565\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1132935565?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-03 18:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1132935565","market":"other","top_or_hot":-1,"title":"Guangzhou Baiyunshan Pharmaceutical Holdings (600332.SH): Ceftazidime for Injection Passes Generic Drug Consistency Evaluation","media":"Stock News","content":"<p>Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SH) announced that its controlling subsidiary, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. (\"Tianxin Pharmaceutical\"), has received the \"Drug Supplemental Application Approval Notice\" issued by the National Medical Products Administration. The company's Ceftazidime for Injection (0.5g, 1.0g) has successfully passed the generic drug quality and efficacy consistency evaluation.</p>\n<p>Ceftazidime for Injection is a third-generation cephalosporin antibiotic indicated for the treatment of single or multiple infections caused by susceptible microorganisms, including: systemic severe infections; lower respiratory tract infections (including pneumonia); ear, nose, and throat infections; urinary tract infections; skin and soft tissue infections; bone and joint infections; gynecological infections; gastrointestinal, biliary, and abdominal infections; hemodialysis/peritoneal dialysis and continuous ambulatory peritoneal dialysis (CAPD)-related infections; central nervous system infections (including meningitis); and prevention of perioperative urinary tract infections.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Guangzhou Baiyunshan Pharmaceutical Holdings (600332.SH): Ceftazidime for Injection Passes Generic Drug Consistency Evaluation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGuangzhou Baiyunshan Pharmaceutical Holdings (600332.SH): Ceftazidime for Injection Passes Generic Drug Consistency Evaluation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-09-03 18:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SH) announced that its controlling subsidiary, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. (\"Tianxin Pharmaceutical\"), has received the \"Drug Supplemental Application Approval Notice\" issued by the National Medical Products Administration. The company's Ceftazidime for Injection (0.5g, 1.0g) has successfully passed the generic drug quality and efficacy consistency evaluation.</p>\n<p>Ceftazidime for Injection is a third-generation cephalosporin antibiotic indicated for the treatment of single or multiple infections caused by susceptible microorganisms, including: systemic severe infections; lower respiratory tract infections (including pneumonia); ear, nose, and throat infections; urinary tract infections; skin and soft tissue infections; bone and joint infections; gynecological infections; gastrointestinal, biliary, and abdominal infections; hemodialysis/peritoneal dialysis and continuous ambulatory peritoneal dialysis (CAPD)-related infections; central nervous system infections (including meningitis); and prevention of perioperative urinary tract infections.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00874","symbol_name":"白云山","start_time":0,"source_url":"","article_id":"1132935565","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1132935565","pubTimestamp":1756894227,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SH) announced that its controlling subsidiary, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. (\"Tianxin Pharmaceutical\"),...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600332":"白云山","00874":"白云山","BK0097":"医药电商","BK0028":"国家队","BK1197":"保健护理产品经销商","BK0239":"医药制造","BK0183":"MSCI概念","BK1515":"抗疫概念","BK0096":"民营医院","BK1191":"制药","BK0188":"融资融券","BK1521":"挪威政府全球养老基金持仓","BK1606":"中医药概念","BK0070":"员工持股","BK0175":"白马股","BK0196":"行业龙头","BK0012":"证金概念"},"translate_title":"广州白云山医药控股（600332.SH）：注射用头孢他啶通过仿制药一致性评价","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600332":1,"00874":1},"content_text":"Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SH) announced that its controlling subsidiary, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. (\"Tianxin Pharmaceutical\"), has received the \"Drug Supplemental Application Approval Notice\" issued by the National Medical Products Administration. The company's Ceftazidime for Injection (0.5g, 1.0g) has successfully passed the generic drug quality and efficacy consistency evaluation.\nCeftazidime for Injection is a third-generation cephalosporin antibiotic indicated for the treatment of single or multiple infections caused by susceptible microorganisms, including: systemic severe infections; lower respiratory tract infections (including pneumonia); ear, nose, and throat infections; urinary tract infections; skin and soft tissue infections; bone and joint infections; gynecological infections; gastrointestinal, biliary, and abdominal infections; hemodialysis/peritoneal dialysis and continuous ambulatory peritoneal dialysis (CAPD)-related infections; central nervous system infections (including meningitis); and prevention of perioperative urinary tract infections.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}